These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 36700382)
1. Lactoferrin regulates sebogenesis and inflammation in SZ95 human sebocytes and mouse model of acne. Su YT; Zouboulis CC; Cui W; Zhang AP J Cosmet Dermatol; 2023 Apr; 22(4):1361-1368. PubMed ID: 36700382 [TBL] [Abstract][Full Text] [Related]
2. Regulation of stearoyl-coenzyme A desaturase and fatty acid delta-6 desaturase-2 expression by linoleic acid and arachidonic acid in human sebocytes leads to enhancement of proinflammatory activity but does not affect lipogenesis. Zouboulis CC; Angres S; Seltmann H Br J Dermatol; 2011 Aug; 165(2):269-76. PubMed ID: 21457203 [TBL] [Abstract][Full Text] [Related]
3. Increased Lipid Accumulation under Hypoxia in SZ95 Human Sebocytes. Choi K; Jin M; Zouboulis CC; Lee Y Dermatology; 2021; 237(1):131-141. PubMed ID: 32088721 [TBL] [Abstract][Full Text] [Related]
4. Expression of Protease-Activated Receptor-2 in SZ95 Sebocytes and its Role in Sebaceous Lipogenesis, Inflammation, and Innate Immunity. Lee SE; Kim JM; Jeong SK; Choi EH; Zouboulis CC; Lee SH J Invest Dermatol; 2015 Sep; 135(9):2219-2227. PubMed ID: 25880702 [TBL] [Abstract][Full Text] [Related]
5. Expression of lipogenic factors galectin-12, resistin, SREBP-1, and SCD in human sebaceous glands and cultured sebocytes. Harrison WJ; Bull JJ; Seltmann H; Zouboulis CC; Philpott MP J Invest Dermatol; 2007 Jun; 127(6):1309-17. PubMed ID: 17363919 [TBL] [Abstract][Full Text] [Related]
6. 11β-hydroxysteroid dehydrogenase type 1 is expressed in human sebaceous glands and regulates glucocorticoid-induced lipid synthesis and toll-like receptor 2 expression in SZ95 sebocytes. Lee SE; Kim JM; Jeong MK; Zouboulis CC; Lee SH Br J Dermatol; 2013 Jan; 168(1):47-55. PubMed ID: 22897663 [TBL] [Abstract][Full Text] [Related]
7. Macrophage-activating lipopeptide-2 and corticotropin-releasing hormone stimulate the inflammatory signalling in human sebocytes through activation of stearoyl-CoA desaturase and fatty acid desaturase 2. Zouboulis CC; Angres S J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):493-501. PubMed ID: 33131141 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological PPARγ modulation regulates sebogenesis and inflammation in SZ95 human sebocytes. Mastrofrancesco A; Ottaviani M; Cardinali G; Flori E; Briganti S; Ludovici M; Zouboulis CC; Lora V; Camera E; Picardo M Biochem Pharmacol; 2017 Aug; 138():96-106. PubMed ID: 28461124 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol ameliorates lipid accumulation and inflammation in human SZ95 sebocytes via the AMPK signaling pathways in vitro. Wei Z; Chen G; Hu T; Mo X; Hou X; Cao K; Wang L; Pan Z; Wu Q; Li X; Ye F; Zouboulis CC; Ju Q J Dermatol Sci; 2021 Sep; 103(3):156-166. PubMed ID: 34334258 [TBL] [Abstract][Full Text] [Related]
10. Emodin exhibits anti-acne potential by inhibiting cell growth, lipogenesis, and inflammation in human SZ95 sebocytes. Liu S; Luo XH; Liu YF; Zouboulis CC; Shi G Sci Rep; 2023 Dec; 13(1):21576. PubMed ID: 38062074 [TBL] [Abstract][Full Text] [Related]
11. Autophagy regulates lipid production and contributes to the sebosuppressive effect of retinoic acid in human SZ95 sebocytes. Seo SH; Jung JY; Park K; Hossini AM; Zouboulis CC; Lee SE J Dermatol Sci; 2020 May; 98(2):128-136. PubMed ID: 32354609 [TBL] [Abstract][Full Text] [Related]
12. The Effects of Synthetic SREBP-1 and PPAR-γ Decoy Oligodeoxynucleotide on Acne-like Disease In Vivo and In Vitro via Lipogenic Regulation. Gu H; An HJ; Gwon MG; Bae S; Zouboulis CC; Park KK Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551286 [TBL] [Abstract][Full Text] [Related]
13. Minocycline suppresses lipogenesis via inhibition of p300 histone acetyltransferase activity in human SZ95 sebocytes. Shin HS; Zouboulis CC; Kim MK; Lee DH; Chung JH J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1325-1333. PubMed ID: 35285066 [TBL] [Abstract][Full Text] [Related]
14. Alterations in IL-4, IL-10 and IFN-γ levels synergistically decrease lipid content and protein expression of FAS and mature SREBP-1 in human sebocytes. Shin J; Kim KP; Ahn HY; Kim B; Cho Y Arch Dermatol Res; 2019 Sep; 311(7):563-571. PubMed ID: 31127384 [TBL] [Abstract][Full Text] [Related]
15. LXRalpha enhances lipid synthesis in SZ95 sebocytes. Hong I; Lee MH; Na TY; Zouboulis CC; Lee MO J Invest Dermatol; 2008 May; 128(5):1266-72. PubMed ID: 17960176 [TBL] [Abstract][Full Text] [Related]
16. ALA-PDT suppressing the cell growth and reducing the lipogenesis in human SZ95 sebocytes by mTOR signaling pathway in vitro. Tuo J; Wang Q; Zouboulis CC; Liu Y; Ma Y; Ma L; Ying J; Zhang C; Xiang L Photodiagnosis Photodyn Ther; 2017 Jun; 18():295-301. PubMed ID: 28330814 [TBL] [Abstract][Full Text] [Related]
17. Leptin promotes a proinflammatory lipid profile and induces inflammatory pathways in human SZ95 sebocytes. Törőcsik D; Kovács D; Camera E; Lovászi M; Cseri K; Nagy GG; Molinaro R; Rühl R; Tax G; Szabó K; Picardo M; Kemény L; Zouboulis CC; Remenyik É Br J Dermatol; 2014 Dec; 171(6):1326-35. PubMed ID: 24975960 [TBL] [Abstract][Full Text] [Related]
18. Formalin-killed Propionibacterium acnes activates the aryl hydrocarbon receptor and modifies differentiation of SZ95 sebocytes in vitro. Cao K; Chen G; Chen W; Hou X; Hu T; Lu L; Wang L; Pan Z; Wu Q; Li X; Wei Z; Ma Y; Zouboulis CC; Ju Q Eur J Dermatol; 2021 Feb; 31(1):32-40. PubMed ID: 33648912 [TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin-3-gallate suppresses IGF-I-induced lipogenesis and cytokine expression in SZ95 sebocytes. Im M; Kim SY; Sohn KC; Choi DK; Lee Y; Seo YJ; Kim CD; Hwang YL; Zouboulis CC; Lee JH J Invest Dermatol; 2012 Dec; 132(12):2700-8. PubMed ID: 22763784 [TBL] [Abstract][Full Text] [Related]
20. Desaturation of sebaceous-type saturated fatty acids through the SCD1 and the FADS2 pathways impacts lipid neosynthesis and inflammatory response in sebocytes in culture. Flori E; Mastrofrancesco A; Ottaviani M; Maiellaro M; Zouboulis CC; Camera E Exp Dermatol; 2023 Jun; 32(6):808-821. PubMed ID: 36843338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]